Cardiovascular disease in pregnancy: Prevalence and obstetric outcomes in a Swedish population-based cohort study

Teresia Svanvik1,2, Rema Ramakrishnan2, Martin Svensson3

  • 1Department of Obstetrics and Gynecology, Institute of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden.

Insights

Cardiovascular disease in pregnancy is rising in Sweden, mainly due to arrhythmias. Diagnosis timing impacts outcomes for mothers and babies, especially in first-time mothers, highlighting the need for vigilant monitoring.

Area of Science:

  • Obstetrics and Gynecology
  • Cardiology
  • Public Health

Background:

  • Cardiovascular disease (CVD) in pregnancy, diagnosed before, during, or up to 6 months postpartum, poses risks not previously detailed in Sweden.
  • This study investigates CVD prevalence trends and associated maternal/perinatal outcomes in Sweden.

Purpose of the Study:

  • To analyze the trends in cardiovascular disease prevalence among pregnant women in Sweden from 2000-2019.
  • To examine the association between cardiovascular disease diagnosed during pregnancy and adverse maternal and perinatal outcomes.
  • To assess the impact of the timing of cardiovascular disease diagnosis (pre-pregnancy, during pregnancy, postpartum) on outcomes.

Main Methods:

  • Population-based retrospective cohort study using the Swedish Medical Birth Register (2000-2019).
  • Prevalence calculated as annual CVD diagnoses per pregnant woman.
  • Adverse outcomes analyzed using time-dependent Cox and Poisson regression models, with follow-up up to one year postpartum.

Main Results:

  • CVD prevalence in pregnant women increased from 0.31% to 1.34%, largely driven by arrhythmias.
  • Primiparous women with CVD faced higher risks of eclampsia, psychiatric admission, and one-year mortality, with timing of diagnosis being significant.
  • Children born to mothers with CVD had increased risks of preterm birth and being small for gestational age.

Conclusions:

  • A significant rise in cardiovascular disease prevalence among pregnant women in Sweden was observed, primarily due to arrhythmias.
  • The timing of cardiovascular disease diagnosis, particularly postpartum diagnosis, is critical for maternal and perinatal outcomes in primiparous women.
  • Enhanced awareness and monitoring of pregnant women with CVD throughout pregnancy and postpartum are crucial for all healthcare staff.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
7
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
828
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
103
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
280
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
25